Issue Date: January 21, 2013
BASF Boosts Offer For Pronova
Unable to lock up the 90% of shares it needs to complete the acquisition of nutritional supplements maker Pronova BioPharma from minority shareholders, BASF has increased its per-share offer for the Norwegian firm by 8%. The deal, originally announced in November, would give BASF a maker of concentrated omega-3 fatty acids from fish. BASF now values the deal at $909 million, including liabilities, up from $883 million.
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society